MRK - Merck & Company - Stock Price & Dividends

Merck & Co., Inc. is a global healthcare company that operates through two primary segments: Pharmaceutical and Animal Health. The Pharmaceutical segment is responsible for developing and marketing a wide range of human health pharmaceutical products, including treatments for cancer, infectious diseases, and chronic conditions such as diabetes and cardiovascular disease. Some of its well-known brands include Keytruda, Bridion, Adempas, and Januvia, as well as vaccine products like Gardasil and M-M-R II.

The company's Pharmaceutical segment also focuses on research and development, with partnerships and agreements in place with other leading pharmaceutical companies, such as Daiichi Sankyo, AstraZeneca, and Eisai, to co-develop and co-commercialize new treatments for various types of cancer and other diseases. This collaborative approach enables Merck to stay at the forefront of medical innovation and expand its portfolio of products.

The Animal Health segment, on the other hand, is dedicated to discovering, developing, and marketing veterinary pharmaceuticals, vaccines, and health management solutions and services. This segment also offers digitally connected identification, traceability, and monitoring products, which help animal health professionals and pet owners to better care for animals. Merck's Animal Health segment serves a diverse range of customers, including veterinarians, animal producers, farmers, and pet owners.

In terms of its customer base, Merck & Co., Inc. serves a broad range of clients, including drug wholesalers and retailers, hospitals, government agencies, managed health care providers, and physicians. The company's products are distributed globally, and it has a strong presence in many countries around the world.

With a rich history dating back to 1891, Merck & Co., Inc. is headquartered in Rahway, New Jersey, and has established itself as a leader in the global healthcare industry. The company's commitment to innovation, research, and development has enabled it to make significant contributions to human and animal health, and it continues to be a major player in the pharmaceutical and healthcare sectors.